Safety and Efficacy of Pembrolizumab in Combination With FLOT About Gastroesophageal Junction Cancer:
Clinical trial NCT06411171 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06411171
- Sponsor
- xiaohua li
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-09-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.